Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSQKUkU6BamPthrRqjBZt2gsyyVHMXDs9O5Tu088hVKWTozKD3yBO/nf2/f3zycnF5p55a0BJBe/7rSDyPeCpyCi/6/vT26tm7F8MGsmKrMnea70gClpt30sZkbLvl6PBHAiXwc/rr59Afw/oDxpeIuYrSNWr9wpFWfCFyOU1yct3vGQtaObdg1qKrO/nhdo+9RKpUGcxeBT4W+YkhSTcPdkfXc3O9p8nYSl2gGohAb8SfmcUXaCVZlogAldDouBO4JNZOp214967KIqtQlA5ASkKTGFM1HKMYk0zyMyRCJNgFWTxmN0ArhmoMohRPFyl99JKnKzIZgIPI3PSH/ToUG1UM2q2er32WavbaUWtdtcqFO4tldk8ehJhnmM2a5/H3U7cCxcYZigY5Irwpv6VA9JMMMtajQUqwhxVicrha785ioPw8KYbMipzRp6Clcxtl4og0cOAmgruJlLO4BY1p5hes3/0ecFY+J9ZT3cUcZRxCamhKLiqgcnVxHYhhoIr2NRX1I5/arPzIgV5Otk/gpvZPy7mjKa2iNMQKkCq6WRUTziXcPhIJEzRHR1+UJ6JR3l66uxX2VH2+RacRtF81om68XnH/tj/pf1Uc/xcFmVVQw0jKo9hzIgvxLF00RY1Sz0b1Jk3t72RSAmDmu6oaQkebcrnZs6Z7d1tqWrAKPr58tbWLt8LwKeb7V+jNM36+4W2A7ML2mt/vpV7tY37x23ZSuSApvos7rTt/I5m1CyVyuX7MFwS2ZREL2Ggd9nBx8LFSWaveftSPHf9vpN+oOqPKtw6Sn1eHaKHl892m77VLRzbAe++33XaxhgKCziiDhXRnXF3dHl6lL+0v87SHr+ii7sw21aVKCq4q5apmJsZfOzhoUvLr1Dz4dtiQWtuYWqtmYTVDdCgkYTl7c+g8RdxoQ9Q
yEaEZDmWwamauHds